Qualigen Therapeutics Finds $8M In PIPE
socalTECH
JULY 13, 2020
Carlsbad-based Qualigen Therapeutics said on Friday that it has raised $8M in new funding, from a single institutional investor. The company--which trades on the NASDAQ as QLGN--said it sold 1,140,570 shares of its Common Shares, 780,198 Pre-Funded Warrants and 1,920,768 Common Warrants at a combined purchase price of $4.165. The company said those Common Warrants have an exercise price of $5.25 per share, are exercisable immediately and have a term of two years.
Let's personalize your content